Luca Miele

13.3k total citations · 2 hit papers
193 papers, 6.7k citations indexed

About

Luca Miele is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Luca Miele has authored 193 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Epidemiology, 55 papers in Hepatology and 38 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Luca Miele's work include Liver Disease Diagnosis and Treatment (119 papers), Diet, Metabolism, and Disease (34 papers) and Diet and metabolism studies (27 papers). Luca Miele is often cited by papers focused on Liver Disease Diagnosis and Treatment (119 papers), Diet, Metabolism, and Disease (34 papers) and Diet and metabolism studies (27 papers). Luca Miele collaborates with scholars based in Italy, United States and United Kingdom. Luca Miele's co-authors include Antonio Grieco, Antonio Gasbarrini, Luca Valenti, Fabio Maria Vecchio, Alessandra Forgione, Venanzio Valenza, Giovanni Cammarota, Giuseppe La Torre, Anna Alisi and Valério Nobili and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Luca Miele

184 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease†

2009 1.1k citations Luca Miele, Giovanni Cammarota et al. profile →
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups

2015 353 citations Antonio Grieco, Luca Miele et al. Digestive and Liver Disease profile →

Peers

Countries citing papers authored by Luca Miele

Since Specialization

Citations

This map shows the geographic impact of Luca Miele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Miele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Miele more than expected).

Fields of papers citing papers by Luca Miele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Miele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Miele. The network helps show where Luca Miele may publish in the future.

Co-authorship network of co-authors of Luca Miele

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Miele. A scholar is included among the top collaborators of Luca Miele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Miele. Luca Miele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort 2025 ·Biomedicines ·Antonio Liguori, (unknown), Maria Elena Ainora, Mignini Irene, (unknown), (unknown), (unknown), Maria Cristina Giustiniani, Laura Riccardi, Matteo Garcovich, Antonio Gasbarrini, Luca Miele, Maria Assunta Zocco	2
2	Carriage of rare pathogenic apob variants predispose to severe masld and hcc 2025 ·Digestive and Liver Disease ·(unknown), Serena Pelusi, (unknown), (unknown), (unknown), (unknown), (unknown), Misty Saracino, (unknown), (unknown), (unknown), Salvatore Petta, (unknown), Luca Miele, Umberto Vespasiani‐Gentilucci, (unknown), (unknown), C Schneider, (unknown), (unknown)	0
3	Serum‐free light chains as a dependable biomarker for stratifying patients with metabolic dysfunction‐associated steatotic liver disease 2024 ·Liver International ·(unknown), (unknown), Cecilia Napodano, (unknown), Maria Cristina Giustiniani, Maurizio Pompili, Antonio Grieco, Gianludovico Rapaccini, Andrea Urbani, Antonio Gasbarrini, Umberto Basile, Luca Miele	2
4	Effect of Low-Dose Alcohol Consumption on Chronic Liver Disease 2024 ·Nutrients ·(unknown), (unknown), Luca Miele, Giovanni Addolorato, Antonio Gasbarrini, Francesca Romana Ponziani	1
5	Exploring the Role of Bempedoic Acid in Metabolic Dysfunction Associated Steatotic Liver Disease: Actual Evidence and Future Perspectives 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), Mignini Irene, (unknown), Maria Elena Ainora, Luca Miele, Antonio Gasbarrini, Maria Assunta Zocco	7
6	Interplay of Oxidative Stress, Gut Microbiota, and Nicotine in Metabolic-Associated Steatotic Liver Disease (MASLD) 2024 ·Antioxidants ·Mignini Irene, (unknown), Giulia Piccirilli, (unknown), (unknown), (unknown), (unknown), Luca Miele, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco	9
7	Evaluation of ChatGPT as a Counselling Tool for Italian-Speaking MASLD Patients: Assessment of Accuracy, Completeness and Comprehensibility 2024 ·Journal of Personalized Medicine ·Nicola Pugliese, Davide Polverini, Rosa Lombardi, Grazia Pennisi, Federico Ravaioli, Angelo Armandi, Elena Buzzetti, Andrea Dalbeni, Antonio Liguori, Alessandro Mantovani, Rosanna Villani, Ivan Gardini, Cesare Hassan, Luca Valenti, Luca Miele, Salvatore Petta, Giada Sebastiani, Alessio Aghemo, (unknown)	6
8	Gut microbiome and metabolic dysfunction-associated steatotic liver disease: Pathogenic role and potential for therapeutics 2024 ·Best Practice & Research Clinical Gastroenterology ·Sandra G. García, (unknown), Francesca Romana Ponziani, Luca Miele, Antonio Gasbarrini, Giovanni Cammarota, Ángel Lanas, (unknown)	5
9	Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves 2023 ·Internal and Emergency Medicine ·Luca Miele, (unknown), (unknown), (unknown), (unknown), Antonio Liguori, Carlotta Masciocchi, (unknown), Mignini Irene, Tommaso Schepis, Giuseppe Marrone, Marco Biolato, Alfredo Cesario, Stefano Patarnello, Andrea Damiani, Antonio Grieco, Vincenzo Valentini, Antonio Gasbarrini, (unknown)	2
10	Urinary lithogenic profile of patients with non-alcoholic fatty liver disease 2023 ·Nephrology Dialysis Transplantation ·Matteo Bargagli, (unknown), Cecilia Napodano, Silvia Baroni, (unknown), Fabrizio Pizzolante, Nicoletta De Matthaeis, (unknown), Antonio Grieco, Antonio Gasbarrini, Giovanni Gambaro, Pietro Manuel Ferraro, Luca Miele	3
11	The Liver in Heart Failure: From Biomarkers to Clinical Risk 2023 ·International Journal of Molecular Sciences ·Nadia Aspromonte, (unknown), (unknown), (unknown), Antonio Liguori, Antonio Gasbarrini, Massimo Massetti, Luca Miele	7
12	Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues 2023 ·Cancers ·Giuseppe Marrone, (unknown), Marco Biolato, Antonio Liguori, Giuseppe Bianco, Gabriele Spoletini, Antonio Gasbarrini, Luca Miele, Maurizio Pompili	4
13	Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered 2019 ·Nutrients ·Maria Corina Plaz Torres, Alessio Aghemo, Ana Lleò, Giorgia Bodini, Manuele Furnari, Elisa Marabotto, Luca Miele, Edoardo G. Giannini	75
14	Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics 2019 ·Cancers ·Quirino Lai, Alessandro Vitale, Tommaso Maria Manzia, Francesco Giuseppe Foschi, Giovanni Battista Levi Sandri, Martina Gambato, Fabio Melandro, Francesco Paolo Russo, Luca Miele, Luca Viganò, Patrizia Burra, Edoardo G. Giannini, (unknown)	36
15	A Role for the Biological Clock in Liver Cancer 2019 ·Cancers ·Gianluigi Mazzoccoli, Luca Miele, Giuseppe Marrone, Tommaso Mazza, Manlio Vinciguerra, Antonio Grieco	16
16	Treatment of early stage chronic hepatitis C virus infection 2018 ·Expert Review of Clinical Pharmacology ·Francesca Romana Ponziani, Luca Miele, Annalisa Tortora, Manuele Furnari, Giorgia Bodini, Maurizio Pompili, Antonio Gasbarrini, Edoardo G. Giannini	4
17	Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind. 2017 ·PubMed ·Giuseppe Marrone, (unknown), Marco Biolato, Luca Miele, Antonio Liguori, (unknown), Francesca Romana Ponziani, Nadia Mores, Antonio Gasbarrini, Antonio Grieco	27
18	Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study 2017 ·Nutrition Metabolism and Cardiovascular Diseases ·(unknown), José Tadeu Stefano, Luca Miele, Francesca Romana Ponziani, (unknown), (unknown), (unknown), Kyoko Toda, Daniel Ferraz de Campos Mazo, Éster Cerdeira Sabino, F.J. Carrilho, Antonio Gasbarrini, Cláudia P. Oliveira	109
19	Pathophysiology of Non Alcoholic Fatty Liver Disease 2016 ·International Journal of Molecular Sciences ·Salvatore Petta, Amalia Gastaldelli, Eleni Rebelos, Elisabetta Bugianesi, Piergiorgio Messa, Luca Miele, Gianluca Svegliati‐Baroni, Luca Valenti, Ferruccio Bonino	124
20	Pharmacokinetics of Sunitinib in Patients with Liver Cirrhosis and Hepatocellular Carcinoma 2014 ·Annals of Oncology ·(unknown), Michele Basso, Elena Strocchi, (unknown), Luca Miele, (unknown), Maurizio Pompili, (unknown), Carlo Barone	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact